Company: BDRX
Filing Date: 2025-01-17
Form Type: F-1
Source: 0001214659-25-000922
Chunk: 5

Company: Biodexa Pharmaceuticals Plc
Filing Date: 2025-01-17
Form: F-1
Chunk 5
---
 other information that others may give you. Neither we nor the Selling Shareholder will make an offer to sell these
securities in any jurisdiction where such offer or sale is not permitted. No dealer, salesperson or other person is authorized to give
any information or to represent anything not contained in this prospectus, any applicable prospectus supplement or any related free writing
prospectus. You should assume that the information appearing in this prospectus or any prospectus supplement is accurate as of the date
on the front of those documents only, regardless of the time of delivery of this prospectus or any applicable prospectus supplement, or
any sale of a security. Our business, financial condition, results of operations and prospects may have changed since those dates.

The
Selling Shareholder and its permitted transferees may use this registration statement to sell securities from time to time through any
means described in the section titled “Plan of Distribution.” More specific terms of any securities that the Selling
Shareholder and its permitted transferees offer and sell may be provided in a prospectus supplement that describes, among other things,
the specific amounts and prices of the securities being offered and the terms of the offering.

We
may also provide a prospectus supplement or post-effective amendment to the registration statement to add information to, or update or
change information contained in, this prospectus. Any statement contained in this prospectus will be deemed to be modified or superseded
for purposes of this prospectus to the extent that a statement contained in such prospectus supplement or post-effective amendment modifies
or supersedes such statement. Any statement so modified will be deemed to constitute a part of this prospectus only as so modified, and
any statement so superseded will be deemed not to constitute a part of this prospectus. You should read both this prospectus and any applicable
prospectus supplement or post-effective amendment to the registration statement together with the additional information to which we refer
you in the sections of this prospectus titled “Where You Can Find More Information.”

This
prospectus contains summaries of certain provisions contained in some of the documents described herein, but reference is made to the
actual documents for complete information. All of the summaries are qualified in their entirety by the actual documents. Copies of some
of the documents referred to herein have been filed or will be filed as exhibits to the registration statement of which this prospectus
is a part, and you may obtain copies of those documents as described below under “Where You Can Find